You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 28, 2023

PRIMATENE MIST Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Primatene Mist, and when can generic versions of Primatene Mist launch?

Primatene Mist is a drug marketed by Armstrong Pharms and Wyeth Cons and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in PRIMATENE MIST is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Primatene Mist

A generic version of PRIMATENE MIST was approved as epinephrine by BPI LABS on July 29th, 2014.

  Try a Trial

Drug patent expirations by year for PRIMATENE MIST

US Patents and Regulatory Information for PRIMATENE MIST

PRIMATENE MIST is protected by one US patents.

Patents protecting PRIMATENE MIST

Stable epinephrine suspension formulation with high inhalation delivery efficiency
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Armstrong Pharms PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 205920-001 Nov 7, 2018 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Wyeth Cons PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 016126-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.